Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2022 Earnings Call Transcript
Operator: Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Third Quarter 2022 Financial Results Conference Call.
Posts Tagged ‘NASDAQ:ATRA’
10 Best Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this piece, we will take a look at the ten best stocks to buy under $20 according to Jeremy Green's Redmile Group.
5 Healthcare Stocks to Buy According to Lee Ainslie’s Maverick Capital
In this piece, we will take a look at the 5 healthcare stocks to buy according to Lee Ainslie's Maverick Capital. If you want to learn more about Mr.
10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green’s Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Hedge Fund Sentiment Is Stagnant On Atara Biotherapeutics Inc (ATRA)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
10 Cheap Value Stocks To Buy According To Seth Klarman
In this article, we discuss the cheap value stocks to buy according to Seth Klarman.
5 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will discuss 5 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Is Atara Biotherapeutics Inc (ATRA) A Good Stock To Buy?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Hedge Fund and Insider Trading News: Dan Kamensky, Bill Ackman, Alan Howard, Paul Tudor Jones, Kyle Bass, Vail Resorts, Inc. (MTN), Corcept Therapeutics Incorporated (CORT), and More
On a summer Friday afternoon last year, hedge-fund manager Dan Kamensky broke bankruptcy laws.
Is ATRA Stock A Buy or Sell?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Hedge Funds Are Crazy About Atara Biotherapeutics Inc (ATRA)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Have Never Been This Bullish On Atara Biotherapeutics Inc (ATRA)
In this article we will check out the progression of hedge fund sentiment towards Atara Biotherapeutics Inc (NASDAQ:ATRA) and determine whether it is a good investment right now...
Hedge Funds Have Never Been More Bullish On Atara Biotherapeutics Inc (ATRA)
"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong.
Did Hedge Funds Drop The Ball On Atara Biotherapeutics Inc (ATRA)?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Were Hedge Funds Right About Flocking Into Atara Biotherapeutics Inc (ATRA) ?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Here is What Hedge Funds Think About Atara Biotherapeutics Inc (ATRA)
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events...
Should You Avoid Atara Biotherapeutics Inc (ATRA)?
We can judge whether Atara Biotherapeutics Inc (NASDAQ:ATRA) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their...
13G Filing: Bridger Management and Atara Biotherapeutics Inc. (ATRA)
You can access the original SEC filing by clicking here.
Best Healthcare Stocks: Billionaire Seth Klarman’s Picks
What are the best healthcare stocks to invest in? Baupost Group was founded in 1982 by Harvard Professor William Poorvu and partners Howard Stevenson, Jordan Baruch and Isaac ...
Atara Biotherapeutics Inc (ATRA): Are Hedge Funds Right About This Stock?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Billionaire Seth Klarman’s Top Biotech Stock Picks
A high majority of hedge fund managers delivered a terrible performance in 2015 and widely-known value investor Seth Klarman was no exception.
What is Happening to These 4 Falling Stocks?
With investors concerned that trouble from the high yield debt market could spread into other sectors, shares of Encana Corporation (USA) (NYSE:ECA), GoPro Inc (NASDAQ:GPRO), ...
Should You Buy Atara Biotherapeutics Inc (ATRA)?
Is Atara Biotherapeutics Inc (NASDAQ:ATRA) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
What Happened To Billionaire Seth Klarman’s Top Biotech Picks In The Third Quarter?
Some investors think billionaire Seth Klarman is the next Warren Buffett. Given that Klarman's $31 billion fund, Baupost Group, has achieved average annual returns of 17% a...
Baupost Group Drops AVEO Pharmaceuticals Inc (AVEO) and Shifts Focus Towards Cheniere Energy (LNG)
Seth Klarman’s Baupost Group shed its entire stake in AVEO Pharmaceuticals Inc (NASDAQ:AVEO), selling off more than 3.82 million Common Shares.
PBF Energy Inc (PBF), Forward Pharma A/S (FWP), Atara Biotherapeutics Inc (ATRA): Seth Klarman’s Baupost Group Is Bullish on Healthcare and Energy Stocks
Seth Klarman’s Baupost Group disclosed last Monday three big stock purchases.
